Planta Med 2010; 76(1): 76-78
DOI: 10.1055/s-0029-1185943
Pharmacology
Letters
© Georg Thieme Verlag KG Stuttgart · New York

Effects of Baicalin on Chlamydia trachomatis Infection in vitro

Huang Hao1 [*] , Yang Aixia1 [*] , Fu Lei1 , Yu Nancai1 , Su Wen1
  • 1Center of Experimental Medicine, Wuhan First Hospital, Wuhan, P. R. China
Further Information

Publication History

received April 8, 2009 revised June 15, 2009

accepted June 18, 2009

Publication Date:
27 July 2009 (online)

Abstract

Baicalin has emerged as a promising agent for the therapy of infectious diseases due to the increasing number of pathogenic microbial strains resistant to several antibiotics. In this study, we investigated the inhibitory activity of baicalin on Chlamydia infection in vitro. We found that baicalin blocked the infection of HeLa cells in vitro when added to the infected cells. In order to shed light on the inhibitory effects of baicalin on the Chlamydia-infected cells, the expression of RFX5 and Chlamydia protease-like activity factor (CPAF) mRNAs and proteins in the Chlamydia-infected cells were examined using Western blot and real-time RT‐PCR analysis. The results demonstrated that RFX5 and CPAF were upregulated and downregulated, respectively, by baicalin. Because CPAF is responsible for degrading RFX5, it is suggested that CPAF is a primary target of baicalin and plays an important role in downregulating RFX5. In conclusion, our findings demonstrated that baicalin can effectively inhibit Chlamydia trachomatis in HeLa cells and therefore can be considered a potential agent for the therapy of infectious diseases caused by C. trachomatis.

References

  • 1 Schachter J, West S K, Mabey D, Dawson C R, Bobo L, Bailey R, Vitale S, Quinn T C, Sheta A, Sallam S, Mkocha H, Mabey D, Faal H. Azithromycin in control of trachoma.  Lancet. 1999;  354 630-635
  • 2 Grayston J T. Chlamydia pneumoniae, strain TWAR pneumonia.  Annu Rev Med. 1992;  43 317-323
  • 3 Kim D H, Jung E A, Sohng I S, Han J A, Kim T H, Han M J. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities.  Arch Pharm Res. 1998;  1 7-23
  • 4 Gao Z, Huang K, Yang X, Xu H. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi.  Biochim Biophys Acta. 1999;  1472 643-650
  • 5 Yude L, Wei W, Song W, Zaoyuan K, Rong L, Yuanshou H. The influence of baicalin on the level of serum TNF-α,IL‐6,IL‐10 in diet-induced hyperlipidemic and CPn infected mice.  J Sichuan Tradit Chin Med. 2006;  24 19-20
  • 6 Zaoyuan K, Linchun F, Haiyan W, Saixia Z. Exploring the mechanism of baicalin in influencing cells infected with Chlamydia pneumoniae by observing its effect on receptors.  J Guangzhou Univ Tradit Chin Med. 2005;  22 210-212
  • 7 Zhong G, Fan P, Ji H, Dong F, Huang Y. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors.  J Exp Med. 2001;  193 935-942
  • 8 Zhong G, Liu L, Fan T, Fan P, Ji H. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in Chlamydia-infected cells.  J Exp Med. 2000;  191 1525-1534
  • 9 Fan P, Dong F, Huang Y, Zhong G. Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors required for major histocompatibility complex antigen expression.  Infect Immun. 2002;  70 345-349
  • 10 Stephens R S. The cellular paradigm of chlamydial pathogenesis.  Trends Microbiol. 2003;  11 44-51
  • 11 Rasmussen S J, Eckmann L, Quayle A J, Shen L, Zhang Y X, Anderson D J, Fierer J, Stephens R S, Kagnoff M F. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis.  J Clin Invest. 1997;  99 77-87
  • 12 Qianqiu W, Huailiang Z, Weihong L. In vitro inhibitive effects of 28 Chinese herbs on Chlamydia trachomatis and herpes simplex virus.  China J AIDS/STD. 2004;  10 279-280
  • 13 Murthy A K, Sharma J, Coalson J J, Zhong G, Arulanandam B P. Chlamydia trachomatis pulmonary infection induces greater inflammatory pathology in immunoglobulin A deficient mice.  Cell Immunol. 2004;  230 56-64
  • 14 Dreses-Werringloer U, Padubrin I, Jürgens-Saathoff B, Hudon A P, Zeidler H, Köhler L. Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro.  Antimicrob Agents Chemother. 2000;  44 3288-3297
  • 15 Zheng J, Wu Y, Liu J, Liu G, Chen C. Early diagnosis using recombinant protein of immunodominant region gene of chlamydial protease-like activity factor from Chlamydophila pneumoniae.  Acta Microbiol Sin. 2008;  48 520-525
  • 16 Lee S O, Jeong Y J, Yu M H, Lee J W, Hwangbo M H, Kim C H, Lee I S. Wogonin suppresses TNF-α-induced MMP‐9 expression by blocking the NF-κB activation via MAPK signaling pathways in human aortic smooth muscle cells.  Biochem Biophys Res Commun. 2006;  351 118-125

1 These authors contributed equally to this work.

Dr. Huang Hao

Center of Experimental Medicine
Wuhan First Hospital

Wuhan 430022

People's Republic of China

Phone: + 862 7 85 33 23 65

Email: whhuanghao10@yahoo.com.cn